Abstract: The invention relates to a method and a device for decoding an image by means of a partition unit comprising an additional region. The method of decoding an image by means of a partition unit comprising an additional region comprises the steps of: partitioning, by reference to a syntax element acquired from a received bit stream, an encoded image, which is included in the bitstream, in at least one partition unit; define an additional region for at least one partition unit; and decoding the encoded image based on the partition unit for which the additional region is defined. The invention improves the image coding efficiency.

Abstract: Provided is photo-sintering nano ink. The photo-sintering nano ink includes a photo-sintering precursor including a conductive nano particle and an oxide film surrounding the conductive nano particle, polymer binder resin, and an adhesive.

Abstract: The present invention relates to a lithium secondary battery including a pre-lithiated carbon-based negative electrode, a positive electrode, a separator, and an inorganic electrolyte represented by the following Formula 1 and a method of preparing the same. LiMX_n(SO2)??[Formula 1] In Formula 1, M is at least one metal selected from an alkali metal, a transition metal, and a post-transition metal, X is a halogen element, and n is an integer of 1 to 4.

Abstract: The present invention pertains to a pharmaceutical composition for preventing or treating squamous cell carcinoma, the pharmaceutical composition containing a highly expressed lncRNAs in esophageal squamous cell carcinoma (HERES) expression inhibitor. More specifically, the present invention pertains to a pharmaceutical composition which uses a HERES expression inhibitor to reduce the expression of HERES and affect Wnt signaling pathways, and thereby prevent or treat squamous cell carcinoma. The present inventors discovered that the expression pattern of HERES is related to the onset of squamous cell carcinoma, and found that HERES can be a target for treating squamous cell carcinoma.

Abstract: Provided is a personalized node ranking (PNR) system and method using random walk. In detail, a personalized ranking method using random walk includes verifying whether propagation of a positive score or a negative score of a currently-visiting node is trustworthy based on an edge sign between a seed node and a next-visiting node predicted by using a classification model, and when the propagation is trustworthy according to the verification, propagating a score by using a first score propagation method based on balance theory, and when the propagation is untrustworthy according to the verification, propagating a score by using a second score propagation method based on a ratio between a balanced triangle and an unbalanced triangle of a signed network.

Abstract: The present disclosure relates to a method and device for providing a V2X service in a next generation radio access technology (new RAT). The present embodiments may provide a method and device for performing sidelink communication by a transmission terminal, the method comprising the steps of: receiving, from a base station, one or more pieces of DMRS pattern information and a resource information set comprising information about one or more sidelink resources; selecting, on the basis of the resource information set, one sidelink resource for performing sidelink communication; selecting, on the basis of the selected one sidelink resource, a particular DMRS pattern from among the one or more pieces of DMRS pattern information; and transmitting a PSCCH and a PSSCH in one slot by using the selected sidelink resource, and transmitting, on the basis of the particular DMRS pattern, a DMRS from a particular symbol of the PSSCH.

Abstract: According to one embodiment of the present invention, A sample inspection device may provided, a total inspection module scanning a first area comprising a plurality of samples; a precision inspection module performing inspection on a sample determined as a suspected defective sample by the total inspection module in the first area; and a controller processing each data obtained from the total inspection module and the precision inspection module, and detecting a defective sample in the first area, wherein the precision inspection module may include an emitter emitting terahertz wave to the first area, a guide wire guiding an irradiation direction of the terahertz wave, and a vibration unit vibrating the guide wire.

Abstract: The present invention relates to a pharmaceutical composition for Alzheimer's treatment containing as an active ingredient of late-stage human mesenchymal stem cells induced into glia-like cells (ghMSCs). When the glia-like cells differentiated from the late-stage human mesenchymal stem cells were co-cultured with neural stem cells having toxicity induced by amyloid beta, effects of increasing the reduced viability and proliferative potential of the neural stem cells and reducing the increased cytotoxicity of the neural stem cells were verified. In addition, the expression of inflammasomes is reduced, and effects of improving long-term memory with respect to spatial perception ability and enhancing spatial cognitive ability in Alzheimer-induced mouse models were verified. Therefore, the pharmaceutical composition of the present invention can be advantageously used in Alzheimer's treatment.

Abstract: A data transmitting and receiving system includes a first device including an encoder configured to encode row data to generate precoding data and a transmitter configured to transmit the precoding data through a transmission channel and a second device including an integrator configured to perform an integral on the precoding data, an integral sampler including a plurality of samplers configured to output sampling data based on an offset value and an output value of the integrator, a decoder configured to decode outputs of some of the samplers to generate decoded data, and a phase detector configured to detect a phase difference between the precoding data and a clock based on the decoded data and an output of another one of the samplers.

Abstract: The present embodiments relate to a method and device for obtaining location information of a terminal by using a wireless communication system. Provided according to an embodiment is a device for acquiring the location information of a terminal, the device comprising at least one downlink signal receiver, at least one uplink signal receiver, and a controller for controlling the downlink signal receiver and uplink signal receiver, wherein the controller configures uplink resource assignment information on the basis of control information received by the downlink signal receiver and determines whether an uplink signal is received, on the basis of the uplink resource allocation information.

Abstract: The present invention relates to a pharmaceutical composition comprising glia-like cells differentiated from human mesenchymal stem cells as an active ingredient for treatment of stroke. Specifically, as a result of injecting the glia-like cells differentiated from human mesenchymal stem cells (ghMSCs) of the present invention to cerebral infarction-induced animal models, the infarct volume remarkably decreased by 50% or more and neural functions were remarkably improved, compared to a control group and a group treated with human mesenchymal stem cells (hMSCs), demonstrating that ischemic stroke (infarction) is treated by the Akt pathway of IGFBP-4 via IGF-1R. Thus, the differentiated glia-like cells of the present invention can be advantageously used as a cell therapy product for stroke.

Abstract: A gesture recognition device and method using radar are proposed. The gesture recognition device includes: a signal receiving unit for receiving a radar signal reflected by a gesture of a user; a clutter removing unit for removing clutter from the signal received by the signal receiving unit; and a signal magnitude variance acquiring unit for acquiring the variance of a signal magnitude from a reflection signal from which the clutter has been removed. The proposed device and method have an advantage of enabling a gesture to be recognized with performance that is robust to changes in distance and direction between a user and a radar sensor.

Abstract: An immersive video processing method according to the present disclosure includes determining a priority order of pruning for source view videos, generating a residual video for an additional view video based on the priority order of pruning, packing a patch generated based on the residual video into an atlas video, and encoding the atlas video.

Abstract: An apparatus for predicting a trajectory of a surrounding vehicle includes a storage configured to store a high definition map, a lane Selection Network (LSN), and a Trajectory Prediction Network (TPN) and a controller that extracts lane information around a target vehicle, traveling around a host vehicle, based on the high definition map, inputs the lane information around the target vehicle and previous trajectory information of the target vehicle to the LSN to detect reference lane information, and inputs the reference lane information and the previous trajectory information of the target vehicle to the TPN to acquire future trajectory information of the target vehicle.

Abstract: The present invention pertains to: a positive electrode active material precursor containing first secondary particle composed of an aggregate of a plurality of first primary particles, the positive electrode active material precursor including a first center portion represented by chemical formula 1 and a first surface portion represented by chemical formula 2, wherein the thickness of the first surface portion is 2-20% of the average radius of the positive electrode active material precursor; and a positive electrode active material containing the positive electrode active material precursor.

Abstract: The present invention relates to a amyotrophic lateral sclerosis (ALS) diagnostic composition using acid sphingomyelinase (ASM), and a method for detecting diagnostic markers and, more specifically, to a method and a composition for detecting markers for ALS, the method comprising the steps of: (a) providing a sample of a subject; (b) measuring the ASM expression level or the enzyme activation level in the sample; (c) determining that a subject, of which the ASM expression level or the enzyme activation level is increased compared to that of a normal person, has ALS. According to the investigation of the present inventors, the activity of ASM, among lipids and enzymes related to the sphingolipid metabolism, is specifically increased in a sample of an ALS patient compared to that of a normal person. ASM can be used as a marker for diagnosing ALS, thereby enabling the development of a novel and effective diagnostic reagent.

Abstract: The present invention relates to a cytosine base-editing composition, and more specifically, to a cytosine base-editing composition comprising adenine deaminase and CRISPR-associated protein 9 (Cas9), or functional analogs thereof, which has a narrow editing window and thus is capable of accurately editing cytosine in a target sequence with another base. The present inventors have discovered that the application of the cytosine base-editing composition comprising adenine deaminase and Cas9, or functional analogs thereof, to a target sequence, causes cytosine on a specific motif to be substituted with another base, and that existing adenine base editors (ABEs) are capable of editing not only adenine but also cytosine, and can also have said substitutions occur with higher accuracy compared to existing cytosine base editors (CBEs).

Abstract: A thickness measuring device of the present invention includes a supporter which supports a specimen, an emission unit which emits an electromagnetic wave in a direction toward the specimen, a chamber which surrounds the specimen, a receiving unit which receives an electromagnetic wave output in a direction in which the chamber is positioned, and a control unit which receives a signal from the receiving unit and calculates a thickness of the specimen. At least a part of the chamber transmits a part of the electromagnetic wave and reflects the remaining part of the electromagnetic wave. The receiving unit receives a first electromagnetic wave having a first peak and a second electromagnetic wave having a second peak. The first peak occurs at a first time point, the second peak occurs at a second time point, and a difference between the first time point and the second time point is a first period or more.

Abstract: The present invention may provide a device and a method for detecting and diagnosing sleep apnea, which can accurately determine an apnea state by: extracting a respiration signal of an examinee from a received signal which is a reflection of an impulse signal emitted from at least one IR-UWB radar; setting a threshold value for determining an apnea state from changes in the deviation and interval between peaks of the extracted respiration signal; and comparing the set threshold value with the deviation between the peaks. Therefore, the sleep apnea can be accurately detected and diagnosed using a non-contact/noninvasive method, and thus inconvenience felt by the examinee can be reduced.

Abstract: The present invention relates to a stent delivery device having: a first support rod into which a first movable body is inserted; a fixed magnet; and a second support rod into which a second movable body is inserted, wherein a first driving magnet included in the first movable body and a second driving magnet included in the second movable body rotate relative to each other by means of the control of an external magnetic field at a predetermined angle around an axis in a first direction with respect to the fixed magnet, thereby separating a first coupling piece and a second coupling piece from a first coupling groove and a second coupling groove and enabling a stent to unfold.